CompletedPhase 2NCT03168711

Safety of Urate Elevation in Amyotrophic Lateral Sclerosis (ALS)

Studying Amyotrophic lateral sclerosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Massachusetts General Hospital
Principal Investigator
Sabrina Paganoni, MD, PhD
Massachusetts General Hospital
Intervention
Inosine(drug)
Enrollment
48 enrolled
Eligibility
18-85 years · All sexes
Timeline
20172020

Study locations (3)

Collaborators

The Salah Foundation · Sean M. Healey & AMG Center for ALS

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03168711 on ClinicalTrials.gov

Other trials for Amyotrophic lateral sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Amyotrophic lateral sclerosis

← Back to all trials